共 47 条
- [1] Ali RR, 2014, REGEN MED, V9, P81, DOI [10.2217/RME.13.78, 10.2217/rme.13.78]
- [2] [Anonymous], 2016, ACCELERATED ACCESS R
- [3] [Anonymous], 2013, NCOB NOV NEUR INT BR
- [4] Bailoni M., 2011, HERODOTE, V4, P162
- [5] Beauchamp T. L., 2019, PRINCIPLES BIOMEDICA
- [6] Chabannon C, 2016, ISBT SCI SER, V11, P271, DOI DOI 10.1111/V0XS.12205
- [7] Christopher Andrea S, 2015, AMA J Ethics, V17, P958, DOI 10.1001/journalofethics.2015.17.10.msoc1-1510
- [8] Claxton K., 2011, Value-Based Pricing for Pharmaceuticals: Its Role, Specification and Prospects in a Newly Devolved NHS
- [9] Cohen R.L., 1987, Social Justice Research, V1, P19, DOI DOI 10.1007/BF01049382
- [10] Innovative regenerative medicines in the EU: a better future in evidence? [J]. BMC MEDICINE, 2017, 15